Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Silver Could Be Close To An Important Resolution

Silver is still in consolidation mode since early September, but could be close to a resolution. Below, is chart of silver: On the chart there appears to have formed some fractals. The current one has also broken out at the blue line in middle to late December of ...

First Majestic Silver, K+S, Scottie Resources - the best entry opportunities

The advantage of volatile markets is that investors can see potential entry prices that they have missed in the past. Whether or not it is still worth taking action now, of course, depends on the future prospects. A price correction in the share price usually has its reasons, ...

All Eyes On Copper

Copper is a fairly strong measure of the strength and capacity of the global economy and global manufacturing. Right now, Copper has been under quite a bit of pricing pressure and has fallen from levels above $4.50 (near 2011) to levels near $2.55. Most recently, Copper has ro...

Kiniksa Pharma Awarded FDA Breakthrough Therapy Status for Pericarditis Treatment Drug

Shares of Kiniksa Pharmaceuticals opened nearly 30% higher today after the firm reported that the FDA granted Breakthrough Therapy designation for Rilonacept for the treatment of recurrent pericarditis. This morning, Hamilton, Bermuda based biopharmaceutical company ...

NEL, dynaCERT, K+S: Where analysts see 280% potential

Innovative technology brings returns to investors. The best example is the share of the Norwegian hydrogen specialist NEL. In the past twelve months, the value has increased by more than 250%. The reason: The mobility revolution is underway and many experts see hydrogen as the...

The Expected and Thrilling Resolution of Oil’s Consolidation

Let's take a closer look at the chart below (chart courtesy of www.stooq.com ) and assess the likely crude oil price path ahead. Yesterday, we wrote: (…) On Friday, crude oil futures bounced off the green gap, which brought about quite a sharp move to the upside....

Oil’s Ongoing Struggle at Multiple Resistances. Resolution Just Ahead?

Although crude oil futures moved a bit higher yesterday, the major resistance zone created by three gaps and the 61.8% Fibonacci retracement again stopped the buyers. A pullback followed, and the futures invalidated the earlier breakout above the previous peaks. Tog...

Idaho Gold Developer Demonstrates Post-Tax 53% IRR

At the 2019 Beaver Creek Precious Metals Summit last week in Beaver Creek, Colorado, I had the opportunity to meet one-on-one with numerous junior mining management teams. Due to a rising gold price environment, the expectation and general mood among the management team...

“Rocking” Copper and Gold Exploration in Canada

(CLICK IMAGE TO PLAY VIDEO) The base and precious metals markets are heating up. And one junior exploration company is taking a fresh look at two high-quality projects in world class mining districts with proven geological potential. Vancouver BC-based Rock...

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million

The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. In an April 30 research note, analyst Joseph Pantginis reported that Oxford Biomedica Plc ...
1 2 3 4 5 6 7 8 9 10 ...